Press Releases

Date	Title and Summary	Additional Formats
February 22, 2008	Aastrom Biosciences Intends to Seek Shareholder Approval to Grant Board Authority to Amend Restated Articles of Incorporation	View HTML Aastrom Biosciences Intends to Seek Shareholder Approval to Grant Board Authority to Amend Restated Articles of Incorporation
February 15, 2008	Aastrom Biosciences Announces Transition of Duties	View HTML Aastrom Biosciences Announces Transition of Duties
February 8, 2008	Aastrom Reports Second Quarter Fiscal Year 2008 Financial Results	View HTML Aastrom Reports Second Quarter Fiscal Year 2008 Financial Results
January 31, 2008	Webcast Alert: Aastrom Announces Second Quarter Investor Conference Call	View HTML Webcast Alert: Aastrom Announces Second Quarter Investor Conference Call
January 17, 2008	Aastrom Biosciences to Present At Leerink Swann Novel Biologics Therapeutics Roundtable Conference	View HTML Aastrom Biosciences to Present At Leerink Swann Novel Biologics Therapeutics Roundtable Conference
January 15, 2008	Aastrom Announces First Patient Treatment With Autologous Stem Cell Therapy for Heart Failure	View HTML Aastrom Announces First Patient Treatment With Autologous Stem Cell Therapy for Heart Failure
December 21, 2007	Aastrom Biosciences Receives Notice Related to NASDAQ Minimum Closing Bid Price Rule	View HTML Aastrom Biosciences Receives Notice Related to NASDAQ Minimum Closing Bid Price Rule
December 7, 2007	Aastrom Biosciences to Present At RBC Capital Markets Healthcare Conference	View HTML Aastrom Biosciences to Present At RBC Capital Markets Healthcare Conference
November 29, 2007	Aastrom Biosciences to Present At BMO Capital Markets Healthcare Conference	View HTML Aastrom Biosciences to Present At BMO Capital Markets Healthcare Conference
November 9, 2007	Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2008 Financial Results	View HTML Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2008 Financial Results

Investor Relations

Press Releases

Company Presentation